Brief: Hcw Biologics Announces Initiation Of First-In-Human Clinical Trial To Evaluate Hcw9302 In An Autoimmune Disease
18/11/2025 12:32
HCW Biologics Inc HCWB.O: HCW BIOLOGICS ANNOUNCES INITIATION OF FIRST-IN-HUMAN CLINICAL TRIAL TO EVALUATE HCW9302 IN AN AUTOIMMUNE DISEASE Source text: ID:nGNX6tqfs2 Further company coverage: HCWB.O
Recent news on Hcw Biologics
See all newsBrief: HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock
Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
Brief: HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM